reagents-immunoassay-tumor-marker-protein-nuclear-matrix-protein-nmp22

Home > Specialties > IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Protein, Nuclear Matrix Protein (NMP22)

IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Protein, Nuclear Matrix Protein (NMP22)

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (typically urine) to determine nuclear mitotic apparatus protein (NMP), a protein that makes up the internal structure of the nucleus (i.e., a nuclear matrix protein) and is usually known as NMP22. Increased levels of NMP22 are found in urine of patients with transitional cell carcinoma of the urinary tract.

Entry Terms : "Nuclear Matrix Protein (NMP22) Determination Reagents" , "NMP22 (Nuclear Matrix Protein 22) Determination Reagents" , "Reagents, Immunoassay, Tumor Marker, Protein, Nuclear Matrix Protein (NMP22)"

UMDC code : 19855

Filters

Manufacturers

Distributors

U.S.companies only

Suppress Subsidiary Companies

1-1 of 1 Match(es).

PerkinElmer Inc

Company Type: Parent

As a global technology leader, PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world.

1-1 of 1 Match(es).

Featured Content

Featured White Papers
	5 Ways to Increase Front Desk Revenue As an independent practice physician, you care about two things when it comes to your practice: patient care and the financial health of your practices. Many physicians go into business for themselves because they want to be independent, and one of the biggest ways to ensure that your practice stays independent is the ability to maximize your revenue stream. Download This Research
	Changing the Perspective Between Call Centers and Patient Loyalty As patients take on more financial burden for their care, their consumer-driven demands are also increasing. They expect healthcare organizations and providers to increase price transparency and deliver more fluid, retail-like experiences, or they will go elsewhere. Healthcare organizations must shift to a new mindset for care delivery--one that connects positive patient experiences with bottom line impacts. . Download This Research
	Preparing Your Practice for MACRA The Medicare Access and CHIP Reauthorization Act of 2015 (his friends just call him MACRA) is the biggest change to physician reimbursement since Medicare was signed into law by President Lyndon Johnson in 1965. So it's understandable that many healthcare professionals are feeling a little overwhelmed with this complex law that covers diverse issues such as data reporting, practice models, evolving clinical standards and physician evaluations. Download This Research

IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Protein, Nuclear Matrix Protein (NMP22)

Featured White Papers

Advanced Search

Information on how to use Search